PROTEASOME INHIBITOR I

PROTEASOME INHIBITOR I 구조식 이미지
카스 번호:
158442-41-2
상품명:
PROTEASOME INHIBITOR I
동의어(영문):
PSI;N-Cb;CS-1340;Z-IE(OTBU)AL-CHO;PROTEASOME INHIBITOR I;ProteasoMe Inhibitor 1;PROTEASOME INHIBITOR PSI;M.W. 618.77 C32H50N4O8;Z-ILE-GLU(OBUT)-ALA-LEU-H;Z-ILE-GLU(OTBU)-ALA-LEU-CHO
CBNumber:
CB8781378
분자식:
C32H50N4O8
포뮬러 무게:
618.76
MOL 파일:
158442-41-2.mol

PROTEASOME INHIBITOR I 속성

끓는 점
844.2±65.0 °C(Predicted)
밀도
1.121±0.06 g/cm3(Predicted)
저장 조건
−20°C
용해도
≥30.6 mg/mL in DMSO; insoluble in H2O; ≥48.7 mg/mL in EtOH
물리적 상태
고체
물리적 상태
단단한 모양
산도 계수 (pKa)
11.12±0.46(Predicted)

안전

WGK 독일 3

PROTEASOME INHIBITOR I C화학적 특성, 용도, 생산

용도

Proteasome Inhibitor 1, is a drug that blocks the action of proteasomes, protein complexes that degrade unneeded and damaged proteins. It is also shown to be used for the treatment of cancer, especially multiple myeloma. Proteasome inhibitors also induce apoptosis and reduce viral replication in primary effusion lymphoma cells.

PROTEASOME INHIBITOR I 준비 용품 및 원자재

원자재

준비 용품


PROTEASOME INHIBITOR I 공급 업체

글로벌( 88)공급 업체
공급자 전화 이메일 국가 제품 수 이점
Alpha Biopharmaceuticals Co., Ltd
+86-411-39042497 +8613921981412
sales@alphabiopharm.com China 886 58
Hubei xin bonus chemical co. LTD
86-13657291602
linda@hubeijusheng.com CHINA 22968 58
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000
marketing@targetmol.com United States 19892 58
Career Henan Chemica Co
+86-0371-86658258 15093356674;
laboratory@coreychem.com China 30256 58
Dideu Industries Group Limited
+86-29-89586680 +86-15129568250
1026@dideu.com China 29831 58
Nextpeptide Inc
+86-0571-81612335 +8613336028439
sales@nextpeptide.com China 19915 58
GIHI CHEMICALS CO.,LIMITED
+8618058761490
info@gihichemicals.com China 50001 58
Nanjing TGpeptide
+86-13347807150 +86-13347807150
support@tgpeptide.com China 3279 58
Shanghai Acmec Biochemical Technology Co., Ltd.
+undefined18621343501
product@acmec-e.com China 33349 58
Amadis Chemical Company Limited
571-89925085
sales@amadischem.com China 132020 58

Copyright 2019 © ChemicalBook. All rights reserved